Foghorn Therapeutics (FHTX) stock Forecast for 2022 – 2026

Foghorn Therapeutics (FHTX) stock Forecast for 2022 – 2026

Last update: 05-24-2022, 8:32

Sector: Healthcare

The share price of Foghorn Therapeutics Inc. (FHTX) now

What analysts predict:: $28.25

52-week high/low: $24.34 / $8.01

50/200 Day Moving Average: $13.07 / $13.44

This figure corresponds to the average price over the previous 50/200 days. For Foghorn Therapeutics stocks, the 50-day moving average is the resistance level today.

For Foghorn Therapeutics stocks, the 200-day moving average is the resistance level today.

Are you interested in Foghorn Therapeutics Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Foghorn Therapeutics stock price in 2022, 2023, 2024, 2025, 2026. How much will one Foghorn Therapeutics share be worth in 2022 - 2026?

When should I take profit in Foghorn Therapeutics stock? When should I record a loss on Foghorn Therapeutics stock? What are analysts' forecasts for Foghorn Therapeutics stock? What is the future of Foghorn Therapeutics stock?

We forecast Foghorn Therapeutics stock performance using neural networks based on historical data on Foghorn Therapeutics stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Foghorn Therapeutics stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2022, 2023, 2024, 2025 and 2026)

The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Foghorn Therapeutics shares. This happens once a day.




Historical and forecast chart of Foghorn Therapeutics stock

The chart below shows the historical price of Foghorn Therapeutics stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Foghorn Therapeutics stock price can be found in the table below.

Long-term forecasts by years.

Foghorn Therapeutics daily forecast for a month

Date Target Pes. Opt. Vol., %
May 26 12.18 11.84 12.61 6.43
May 27 12.36 12.14 12.85 5.86
May 28 12.17 11.98 12.46 4.01
May 29 11.63 11.51 11.98 4.09
May 30 11.58 11.41 11.88 4.06
May 31 11.84 11.42 12.07 5.65
Jun 01 12.04 11.69 12.27 4.89
Jun 02 12.12 11.63 12.53 7.76
Jun 03 11.95 11.77 12.08 2.59
Jun 04 11.89 11.46 12.33 7.52
Jun 05 11.58 11.43 11.75 2.73
Jun 06 11.49 11.34 11.66 2.89
Jun 07 11.65 11.48 11.86 3.30
Jun 08 11.83 11.46 12.20 6.45
Jun 09 11.98 11.76 12.15 3.36
Jun 10 11.88 11.59 12.14 4.77
Jun 11 12.10 11.75 12.46 6.02
Jun 12 12.64 12.35 12.93 4.66
Jun 13 12.66 12.45 13.14 5.54
Jun 14 12.74 12.29 13.00 5.81
Jun 15 12.69 12.49 13.00 4.11
Jun 16 12.52 12.12 12.86 6.09
Jun 17 12.40 12.24 12.88 5.27
Jun 18 12.31 11.94 12.70 6.39
Jun 19 12.51 12.32 12.87 4.47
Jun 20 12.27 12.03 12.47 3.62
Jun 21 12.01 11.75 12.46 5.98
Jun 22 12.08 11.80 12.25 3.79
Jun 23 12.31 12.03 12.44 3.43
Jun 24 12.24 11.96 12.61 5.48

Foghorn Therapeutics Daily Price Targets


Foghorn Therapeutics Stock Forecast 05-26-2022.

Forecast target price for 05-26-2022: $12.18. Positive dynamics for Foghorn Therapeutics shares will prevail with possible volatility of 6.039%.

Pessimistic target level: 11.84

Optimistic target level: 12.61


Foghorn Therapeutics Stock Forecast 05-27-2022.

Forecast target price for 05-27-2022: $12.36. Positive dynamics for Foghorn Therapeutics shares will prevail with possible volatility of 5.531%.

Pessimistic target level: 12.14

Optimistic target level: 12.85


Foghorn Therapeutics Stock Forecast 05-28-2022.

Forecast target price for 05-28-2022: $12.17. Negative dynamics for Foghorn Therapeutics shares will prevail with possible volatility of 3.857%.

Pessimistic target level: 11.98

Optimistic target level: 12.46


Foghorn Therapeutics Stock Forecast 05-29-2022.

Forecast target price for 05-29-2022: $11.63. Negative dynamics for Foghorn Therapeutics shares will prevail with possible volatility of 3.932%.

Pessimistic target level: 11.51

Optimistic target level: 11.98


Foghorn Therapeutics Stock Forecast 05-30-2022.

Forecast target price for 05-30-2022: $11.58. Negative dynamics for Foghorn Therapeutics shares will prevail with possible volatility of 3.899%.

Pessimistic target level: 11.41

Optimistic target level: 11.88


Foghorn Therapeutics Stock Forecast 05-31-2022.

Forecast target price for 05-31-2022: $11.84. Positive dynamics for Foghorn Therapeutics shares will prevail with possible volatility of 5.348%.

Pessimistic target level: 11.42

Optimistic target level: 12.07


FHTX (FHTX) Monthly Stock Prediction for 2022

Month Target Pes. Opt. Vol., %
Jun. 16.10 15.36 16.98 9.56
Jul. 15.66 13.33 17.18 22.41
Aug. 16.16 13.54 18.13 25.27
Sep. 15.07 14.00 17.41 19.63
Oct. 14.53 12.76 16.30 21.72
Nov. 14.41 12.96 15.65 17.21
Dec. 13.32 12.23 14.47 15.47

Foghorn Therapeutics forecast for this year


Foghorn Therapeutics Stock Prediction for Jun 2022

An uptrend is forecast for this month with an optimal target price of $16.1037. Pessimistic: $15.36. Optimistic: $16.98


Foghorn Therapeutics Stock Prediction for Jul 2022

An downtrend is forecast for this month with an optimal target price of $15.664. Pessimistic: $13.33. Optimistic: $17.18


Foghorn Therapeutics Stock Prediction for Aug 2022

An uptrend is forecast for this month with an optimal target price of $16.1575. Pessimistic: $13.54. Optimistic: $18.13


Foghorn Therapeutics Stock Prediction for Sep 2022

An downtrend is forecast for this month with an optimal target price of $15.0717. Pessimistic: $14.00. Optimistic: $17.41


Foghorn Therapeutics Stock Prediction for Oct 2022

An downtrend is forecast for this month with an optimal target price of $14.5336. Pessimistic: $12.76. Optimistic: $16.30


Foghorn Therapeutics Stock Prediction for Nov 2022

An downtrend is forecast for this month with an optimal target price of $14.4115. Pessimistic: $12.96. Optimistic: $15.65


Foghorn Therapeutics Stock Prediction for Dec 2022

An downtrend is forecast for this month with an optimal target price of $13.322. Pessimistic: $12.23. Optimistic: $14.47




Foghorn Therapeutics (FHTX) Monthly Stock Prediction for 2023

Month Target Pes. Opt. Vol., %
Jan 12.73 11.18 14.23 21.42
Feb 14.02 13.37 14.70 9.01
Mar 14.99 14.05 17.04 17.55
Apr 16.03 15.19 17.75 14.42
May 17.24 15.47 20.14 23.19
Jun 18.47 16.22 21.57 24.81
Jul 17.58 15.11 19.68 23.26
Aug 15.81 13.91 16.57 16.03
Sep 16.17 14.03 18.69 24.90
Oct 15.12 13.91 17.06 18.43
Nov 15.18 14.26 17.26 17.37
Dec 16.97 14.19 17.82 20.39

Foghorn Therapeutics (FHTX) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Jan 18.11 17.35 18.91 8.25
Feb 15.67 14.13 18.14 22.13
Mar 16.17 14.61 17.53 16.66
Apr 13.79 12.34 15.91 22.40
May 14.40 13.49 16.34 17.40
Jun 14.97 13.31 16.30 18.33
Jul 16.33 14.75 17.15 13.99
Aug 18.32 17.08 19.74 13.45
Sep 17.43 15.67 18.46 15.07
Oct 16.95 14.60 18.34 20.38
Nov 14.28 13.59 15.18 10.47
Dec 11.94 11.24 12.90 12.84



Foghorn Therapeutics (FHTX) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 12.35 11.28 13.20 14.53
Feb 14.26 12.89 16.33 21.09
Mar 13.67 13.06 15.01 13.00
Apr 13.44 12.03 14.34 16.14
May 12.19 10.71 14.12 24.13
Jun 11.27 10.25 13.02 21.27
Jul 10.37 9.15 11.94 23.35
Aug 10.11 8.94 11.43 21.74
Sep 10.18 8.68 11.22 22.66
Oct 8.70 7.92 9.07 12.70
Nov 7.84 7.38 8.37 11.81
Dec 7.61 7.18 8.51 15.60

Foghorn Therapeutics (FHTX) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 8.59 7.16 9.31 23.05
Feb 10.39 8.91 11.55 22.86
Mar 11.42 10.72 12.59 14.85
Apr 11.30 9.47 12.24 22.67
May 11.65 11.02 12.36 10.89
Jun 12.90 11.17 14.20 21.37
Jul 13.85 12.89 16.17 20.32
Aug 16.64 14.23 17.83 20.19
Sep 14.68 14.00 16.84 16.84
Oct 14.53 12.36 15.41 19.79
Nov 15.96 13.75 17.13 19.76
Dec 13.82 12.31 16.11 23.60

Foghorn Therapeutics information and performance

Foghorn Therapeutics Inc. focuses on the discovery and development of drugs targeting genetically determined addictions in the chromatin regulatory system. The Company’s gene traffic management platform enables it to identify, validate and potentially use drug targets in the chromatin regulatory system. It is initially focused on oncology. The company is developing FHD-286, a selective allosteric ATPase inhibitor, and FHD-609, a protein breaker, for the treatment of hematologic cancers and solid tumors. FHD-286 is an allosteric and orally available, small molecule, enzymatic inhibitor of BRG1 and BRM, which is initially being developed for the treatment of acute myeloid leukemia (AML) and uveal melanoma. FHD-609 is an intravenous, small molecule protein breaker BRD9. The company is also developing complementary programs for large populations, which include selective BRM and selective ARID1B modulators.

Foghorn Therapeutics Address

500 TECHNOLOGY SQUARE, SUITE 700, CAMBRIDGE, MA, US

Market Capitalization: 555 577 000 $

Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.

EBITDA: - $

EBITDA is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: None

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -2.687

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A

Quarterly Revenue Growth YOY: 1.841

Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 38.86

Enterprise Value (EV) /Revenue

EV To EBITDA: -

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 41093000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A

Percent Insiders: N/A

Percent Institutions: N/A




Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.